- Home
- IMNM vs REAL Comparison
IMNM vs REAL Comparison
Compare IMNM & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- REAL
- Stock Information
- Founded
- IMNM 2006
- REAL 2011
- Country
- IMNM United States
- REAL United States
- Employees
- IMNM N/A
- REAL N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- REAL Other Specialty Stores
- Sector
- IMNM Health Care
- REAL Consumer Discretionary
- Exchange
- IMNM Nasdaq
- REAL Nasdaq
- Market Cap
- IMNM 806.1M
- REAL 718.6M
- IPO Year
- IMNM 2020
- REAL 2019
- Fundamental
- Price
- IMNM $6.26
- REAL $5.57
- Analyst Decision
- IMNM Strong Buy
- REAL Buy
- Analyst Count
- IMNM 5
- REAL 6
- Target Price
- IMNM $26.60
- REAL $8.00
- AVG Volume (30 Days)
- IMNM 1.3M
- REAL 2.9M
- Earning Date
- IMNM 03-19-2025
- REAL 05-06-2025
- Dividend Yield
- IMNM N/A
- REAL N/A
- EPS Growth
- IMNM N/A
- REAL N/A
- EPS
- IMNM N/A
- REAL N/A
- Revenue
- IMNM $9,041,000.00
- REAL $600,484,000.00
- Revenue This Year
- IMNM N/A
- REAL $11.61
- Revenue Next Year
- IMNM $476.80
- REAL $9.58
- P/E Ratio
- IMNM N/A
- REAL N/A
- Revenue Growth
- IMNM N/A
- REAL 9.32
- 52 Week Low
- IMNM $6.20
- REAL $2.24
- 52 Week High
- IMNM $22.26
- REAL $11.38
- Technical
- Relative Strength Index (RSI)
- IMNM 26.66
- REAL 40.97
- Support Level
- IMNM $6.94
- REAL $5.25
- Resistance Level
- IMNM $7.68
- REAL $6.99
- Average True Range (ATR)
- IMNM 0.56
- REAL 0.44
- MACD
- IMNM -0.17
- REAL 0.04
- Stochastic Oscillator
- IMNM 2.12
- REAL 18.39
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.